8,499 results on '"Keshavan, A."'
Search Results
152. Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study
153. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort
154. Malignant Hyperthermia Like Manifestations during Management of Refractory Status Epilepticus
155. Cognitive Enhancement Therapy vs social skills training in schizophrenia: a cluster randomized comparative effectiveness evaluation
156. Sex-Specific Changes in Choroid Vasculature Among Patients with Schizophrenia and Bipolar Disorder
157. Blood and cerebrospinal fluid biomarkers for Alzheimer's disease : from clinical to preclinical cohorts
158. Characterizing the Relationship between Personality Dimensions and Psychosis
159. The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis
160. Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia
161. GENE THERAPY PREVENTS HEPATIC MITOCHONDRIAL DYSFUNCTION IN MURINE DEOXYGUANOSINE KINASE DEFICIENCY
162. The Anomalous Effect of COVID-19 Pandemic Restrictions on the Duration of Untreated Psychosis (DUP)
163. 383. Symptom Severity for Psychosis Biotype 3 Shows Unique Associations With Environmental Exposures as Measured By the Exposome Score for Schizophrenia
164. 449. Replication of Hallucination Severity Associating With Reduced Auditory-Language Cortex Connectivity in a Biological Subtype of Psychotic Disorders
165. 398. The Basic Neurocognitive Continuum (BANCC): The Affiliation of Neurobiological and Cognitive Measures in a Data-Based Approach
166. Social Engagement Moderates Relations Between Hippocampal-Temporoparietal Junction Connectivity and Neighborhood Social Fragmentation in Youth at Clinical High Risk for Psychosis
167. Social Determinants of Mental Health in Depression: Comparison of Relative Impact on Prevalence of Major Depressive Disorder
168. 451. Group Iterative Multiple Model Estimation Reveals Individuals at Clinical High-Risk for Psychosis and Healthy Comparisons Self-Organize by Premorbid Adjustment According to Patterns of Temporoparietal Brain Connectivity
169. Towards a Model of Snow Accretion for Autonomous Vehicles
170. Novel Visualization of the Topographical Model of Multiple Sclerosis Using 3D Rendering of Quantified MRI (P11-6.014)
171. Predictive Utility of Serum Protein Biomarkers from the Octave MSDA Panel for Optic Neuritis Events in People with Multiple Sclerosis (S42.008)
172. Operationalizing the centiloid scale for [18F]florbetapir PET studies on PET/MRI
173. Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis
174. Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia
175. A qualitative exploration of perceived needs and barriers of individuals with schizophrenia, caregivers and clinicians in using mental health applications in Madhya Pradesh, India
176. Motivational interviewing for loved ones: Randomized controlled trial of brief training for first episode psychosis caregivers
177. An insight into the mechanisms underpinning the anti-browning effect of Codium tomentosum on fresh-cut apples
178. Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis
179. Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum
180. Precision medicine for psychosis: a revolution at the interface of psychiatry and neurology
181. Better Generalization with Semantic IDs: A case study in Ranking for Recommendations.
182. Schizophrenia
183. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
184. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1
185. Altered amygdala shape trajectories and emotion recognition in youth at familial high risk of schizophrenia who develop psychosis
186. Review of potential psychedelic treatments for PTSD
187. Hazard assessment of abraded thermoplastic composites reinforced with reduced graphene oxide
188. Cognitive gains as a mechanism of functional capacity improvement in schizophrenia: Results from a multi-site randomized controlled trial
189. A Provably Constrained Neural Control Architecture With Prescribed Performance for Fault-Tolerant Redundant Manipulators.
190. Secondary prevention with a structured semi-interactive stroke prevention package in INDIA (SPRINT INDIA): a multicentre, randomised controlled trial
191. Composition of yoga-philosophy based mental traits (Gunas) in major psychiatric disorders: A trans-diagnostic approach
192. What can clozapine’s effect on neural oscillations tell us about its therapeutic effects? A scoping review and synthesis
193. Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study
194. Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study
195. An opportunity for primary prevention research in psychotic disorders
196. Family history of psychosis in youth at clinical high risk: A replication study
197. The 3Dmol.js Learning Environment: A Classroom Response System for 3D Chemical Structures
198. Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis
199. Correction: Cognitive Enhancement Therapy vs social skills training in schizophrenia: a cluster randomized comparative effectiveness evaluation
200. Cognitive Enhancement Therapy vs social skills training in schizophrenia: a cluster randomized comparative effectiveness evaluation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.